JPM Special — Maureen Hillenmeyer, CEO & Founder of Hexagon Bio
In this JPM Special episode of The BioHub, I’m joined by Maureen Hillenmeyer, CEO and Founder of Hexagon Bio.
Maureen has built Hexagon around a bold idea: using genomics, computation, and the biology of natural products to unlock entirely new medicines. At JPM, we sat down to talk about what it really takes to build a platform company in today’s market — from scientific conviction and capital discipline to leadership, culture, and long-term vision.
We also discuss:
What makes Hexagon’s approach fundamentally different
How Maureen thinks about risk, focus, and scale as a founder-CEO
The realities of building biotech through multiple market cycles
A thoughtful, grounded conversation with one of the most impressive founders in the space.
The BioHub - by Avetix